Login

Investing in Southeast Asian companies|Jeffrey Paine,Managing Partner,Golden Gate 00:10:00

Share On Facebook Share On Twitter

One of the most active and respected startup ecosystem leaders in all of Asia.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
This VC Invests In Entrepreneurs Before They Start Companies|Alana Goyal,Founder and Managing Partner,base case capital
00:10:00
Investing in Tomorrow: How AI is Transforming Venture Capital Decisions|Matt Witheiler,partner,Wellington Management
00:10:00
Launching and Scaling Softeq Venture Studio with Texas Entrepreneur|Chris Howard,Founder and Partner,Fuel Capital
00:10:00
Navigating the transition towards sustainable energy, GALP embarks on a transformative journey | FILIPE CRISÓSTOMO SILVA, PRESIDENT, CEO, VICE-CHAIR MAN OF THE BOARD OF DI RECTORS, GALP ENERGIA
00:10:00
Recover Funds from Gorks Bit Scam with MFG Service Inc.
00:10:00
Champion Iron: Greener High-Grade Iron Ore Production Fuels Global Demand and Profitability | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Condoleezza Rice Discusses 9/11, Iraq, and Her Career on Uncommon Knowledge
00:10:00
2024 Annual Investment Outlook: Fixed Income and Structured Notes Overview
00:10:00
Billions of people got access to amazing technologies|Julie Yoo,General Partner,Andreessen Horowitz
00:10:00
Globant's CEO Martin Migoya discusses their new augmented coding concept, set to be unveiled despite the pandemic.
00:10:00
Innovative Pharmaceutical Company Accelerates Growth and Forges Strategic Partnerships |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Filament Health and Reset Pharmaceuticals Strike Licensing Deal for Psilocybin Drug PEX010 | Benjamin Lightburn, CEO , Filament Health Corp.

© 2026 Nehu